Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-26-052993
Filing Date
2026-05-06
Accepted
2026-05-06 21:26:32
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 19294
  Complete submission text file 0001213900-26-052993.txt   20978
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Subject) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91004 | Film No.: 26950476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 20 ACORN PARK DR, CAMBRIDGE, MA 02140 CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DR, CAMBRIDGE, MA 02140 CAMBRIDGE MA 02140 15049574163
Simcere Zaiming, Inc. (Filed by) CIK: 0002080252 (see all company filings)

EIN.: 922412706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A